Skip to main content
Cytogen, Inc. logo

Cytogen, Inc. — Investor Relations & Filings

Ticker · 217330 ISIN · KR7217330000 KO Manufacturing
Open in API
Filings indexed 437 across all filing types
Latest filing 2023-08-21 AGM Information
Country KR South Korea
Listing KO 217330

About Cytogen, Inc.

https://www.cytogenlab.com/

Cytogen, Inc. is a biotechnology company specializing in liquid biopsy platforms for precision oncology. The company has developed proprietary technology for the rapid isolation and analysis of viable Circulating Tumor Cells (CTCs) from whole blood. Its core offering, the SmartBiopsy Platform, utilizes a high-density microporous chip with microfluidics and nanotechnology to capture CTCs efficiently. This non-invasive diagnostic approach is designed to support early cancer detection, treatment monitoring, and the advancement of personalized medicine for cancer patients.

Recent filings

Filing Released Lang Actions
주주총회소집결의(임시주주총회)
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for the company CytoGen, detailing the date, time, location, and agenda items (specifically a proposal to amend the articles of incorporation). This type of document is a standard proxy solicitation or meeting notice sent to shareholders to inform them of an upcoming meeting and the matters to be voted upon. Given the provided categories, 'PSI' (Proxy Solicitation & Information Statement) is the most accurate classification for a notice of meeting and agenda.
2023-08-21 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제4회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korean Exchange (KRX) regarding the 'Acquisition of Convertible Bonds before Maturity'. It details the specific terms of the bond (4th series), the amount acquired (6.55 billion KRW), the reason (Put option exercise), and the method of acquisition. This falls under capital structure changes and financing updates, specifically related to debt instruments.
2023-08-21 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement from Cytogen regarding the setting of a record date for an upcoming Extraordinary General Meeting of shareholders. It does not contain the full proxy materials or the meeting results themselves, but rather serves as a formal notice of the record date for shareholder eligibility. Given the nature of the filing as a standard regulatory disclosure regarding corporate governance procedures, it falls under the general regulatory filing category.
2023-08-21 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'Cytogen' (주식회사 싸이토젠) covering the period from January 1, 2023, to June 30, 2023. It contains detailed corporate information, financial data, business descriptions, and management discussions, which are characteristic of an interim financial report. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year is classified as an Interim / Quarterly Report (IR). H1 2023
2023-08-11 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (Non-Deal Roadshow) scheduled for July 2023. It provides details such as date, location, purpose, and contact information. Since it is an announcement of an event rather than the presentation slides themselves, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it is classified as a Regulatory Filing (RNS) as it serves as a general corporate disclosure of an event.
2023-07-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and purpose of holding (management influence) by major shareholders. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2023-06-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.